- Capital Cube•17 days ago
Aoxing Pharmaceutical Co., Inc. relative valuation is UNDERVALUED and it has a fundamental analysis score of 69.Our analysis is based on comparing Aoxing Pharmaceutical Co., Inc. with the following peers – Pfizer Inc., Catalyst Pharmaceuticals, Inc., BioDelivery Sciences International, Inc., Impax Laboratories, Inc., Johnson & Johnson, Mylan N.V., Omeros Corporation, Amicus Therapeutics, Inc., Onconova Therapeutics […] (Read more...) The post Aoxing Pharmaceutical Co., Inc.: Price momentum supported by strong fundamentals appeared first on CapitalCube.
- Benzinga•25 days ago
Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN ) disclosed that it commenced commercial production of Tilidine Hydrochloride tablets, which is a narcotic drug product. According to the company, this ...
Aoxing Pharmaceutical Company, Inc.NYSE MKT
|Bid||0.77 x 700|
|Ask||0.79 x 4400|
|52wk Range||0.58 - 1.90|
|Day's Range||0.77 - 0.79|
|Avg Vol (3m)||92,211|
As of 1:35 PM EDT. NYSE MKT Real Time Price. Market open.